IntroductIon
In spite of improved perinatal care, invasive bacterial infections still account for more than one million neonatal deaths worldwide annually (1) . The extraordinary vulnerability of the human newborn to infection is generally attributed to its immature adaptive immunity on one hand, and to the immaturity of neonatal neutrophils on the other (2) . Indeed, the pattern of infections in neonates closely parallels that seen in neutropenic oncologic patients. Neonatal phagocytes are characterized by a functional decrease in several defense mechanisms such as impaired chemotaxis and reduced respiratory burst, which severely limit the bactericidal capacity of the neonatal immune system (3) . These developmental immaturities are even more pronounced in premature neonates. Therefore, protection of the neonate by humoral innate defense mechanisms is crucial (4) . Recently, deficiencies within the complement system have been proposed to explain a part of the neonatal susceptibility to infection (5) .
The complement system eliminates microorganisms and enhances the adaptive immune response (6) . Even in the absence of antibodies, the complement system can be activated by the evolutionarily conserved lectin pathway. The lectin pathway consists of four soluble pattern-recognition molecules, mannan-binding lectin (MBL) and M-, L-, and H-ficolins, and of the MBL-associated serine proteases, which are able to activate downstream complement compounds (7) . MBL deficiency has been extensively investigated and is associated with an increased susceptibility to sepsis (5, 8, 9) . In contrast, very little is known on the role of ficolins in health and disease (7) .
M-ficolin (also termed ficolin-1) is unique among the lectin pathway proteins insofar it is synthesized not in the liver but mainly in bone marrow and in circulating leukocytes (10) . M-ficolin is encoded by the FCN1 gene localized on chromosome 9 and consists of subunits each containing a collagen-like strand and three C-terminal recognition domains. M-ficolin binds to microbial surfaces that express N-acetyld-glucosamine or N-acetylgalactosamine and to sialic acid residues (11, 12) . M-ficolin was detected first in monocytes (12, 13) but Liu et al. later reported localization of M-ficolin to neutrophil granula (11) , which has been confirmed by others (14) . Only recently, M-ficolin has been shown to be a serum protein also (15) . However, the role of M-ficolin in host defense against invasive infections remains unknown.
The aim of this study was to investigate the involvement of M-ficolin in neonatal sepsis.
results

Description of Patients
A total of 47 patients who developed blood culture-positive sepsis within the first 30 days of life were enrolled in the study. Their median gestational age was 31 weeks (range [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] When analyzing M-ficolin cord blood concentrations in the entire study population (patients and controls, n = 141), concentrations ranged from 17 to 4,532 ng/ml with a median of 628 ng/ml (interquartile range 377-891). The distribution of M-ficolin concentrations was non-normal, whereas the distribution of the logarithmized concentrations was approximately normal (Kolmogorov-Smirnov statistic Z = 0.06, P = 0.20; Figure 1 ). M-ficolin cord blood concentrations were positively correlated with gestational age (Spearman's ρ 0.33, P < 0.001) and birth weight (ρ 0.32, P < 0.001). Infants born after maternal chorioamnionitis had higher M-ficolin levels as compared with those without chorioamnionitis (adjusted for gestational age, P = 0.003).
M-ficolin Concentration and Differential Leukocyte Count
The FCN1 gene is expressed mainly in the bone marrow and peripheral blood cells (16) . We, therefore, investigated the association of M-ficolin cord blood concentration with differential leukocyte counts obtained immediately after birth (Figure 2 ). M-ficolin cord blood concentration was highly significantly correlated with leukocytes, metamyelocytes, band neutrophils, segmented neutrophils, and monocytes (P < 0.001 for all), whereas myelocytes were less correlated (P = 0.016) and lymphocytes not associated (P = 0.19). The strongest correlations were found for absolute neutrophil count (ρ 0.53, P < 0.001; Figure 2a ) and absolute phagocyte count (i.e., absolute neutrophil count plus monocytes, ρ 0.51, P < 0.001; Figure 2e ). Left shift, calculated as immature/total (I/T) neutrophil ratio, was positively correlated with M-ficolin concentrations (ρ 0.34, P < 0.001; Figure 2f ).
To investigate M-ficolin expression at various neutrophil developmental stages, we labeled cord blood cells with combinations of anti-CD16, anti-CD45, anti-CD66, and anti-Mficolin antibodies. Granulocytes were gated based on their side scatter and CD45 staining intensity. The gated granulocytes were >99% CD66-positive (data not shown), which indicates no presence of monocytes or lymphocytes. The granulocytes were divided into three groups (I, II, and III) based on their surface CD16 expression. No CD16 expression was present on the cells in group I, whereas an intermediate and high expression was present on the cells in groups II and III, respectively (Figure 3a) . Higher staining for anti-M-ficolin was correlated with an increase in CD16 expression (Figure 3b ).
M-ficolin Cord Blood Concentration in Sepsis Patients vs. Controls
M-ficolin cord blood concentrations were higher in infants with EOS than in controls (median 837 vs. 628 ng/ml, Figure 4 and Table 1 ). Based on receiver-operating-characteristic curve analysis, high M-ficolin cord blood concentrations (>1,000 ng/ ml) were defined in contrast to normal M-ficolin concentrations (≤1,000 ng/ml). Six of the 13 (46%) infants with EOS and 6 of 15 (40%) infants with gram-negative sepsis as compared with 17 of 94 (18%) controls had high M-ficolin cord blood concentrations (P = 0.028 for EOS, P = 0.062 for gram-negative sepsis). Multivariate analysis confirmed that high M-ficolin was associated with EOS with an odds ratio of 10.92 (95% confidence interval 2.21-54.02, P = 0.003). In addition, high When limiting the analysis to infants exposed to chorioamnionitis (n = 57), patients developing EOS had higher M-ficolin cord blood concentrations as compared with those not developing EOS (median 844 vs. 571 ng/ml) and high M-ficolin (>1,000 ng/ml) was associated with EOS with an odds ratio of 5.33 (univariate 95% confidence interval 1.17-24.28, P = 0.03).
M-ficolin Release After Exposure to Gram-Negative Bacteria
To investigate whether sepsis may trigger the release of M-ficolin from phagocytes, we measured M-ficolin after experimental exposure to E. coli. In brief, granulocytes, peripheral blood mononuclear cells (PBMCs), and whole citrate blood from adult blood donors were incubated with different inocula of E. coli for 0.5 or 3 h at 37 °C. Subsequently, concentrations of M-ficolin, MBL, L-ficolin, and H-ficolin were measured in the supernatants. Figure 5 shows a time-and dose-dependent increase of M-ficolin after exposure of whole blood (Figure 5a ), purified PBMCs (Figure 5b ), or purified granulocytes (Figure 5c ) to E. coli. No change was found in the other lectin pathway members studied (Figure 5d ). Experiments using Salmonella typhimurium instead of E. coli, yielded similar results (data not shown).
dIscussIon We observed elevated M-ficolin cord blood concentrations in infants with EOS. In addition, M-ficolin concentrations correlated with the absolute phagocyte count and left shift. Experimental exposure of phagocytes to E. coli resulted in a time-and dose-dependent increase in M-ficolin. These findings therefore suggest that bacterial sepsis can trigger M-ficolin release by phagocytes. To the best of our knowledge, this is the first study assessing M-ficolin in invasive infections.
The range and distribution of M-ficolin measured in our cohort are in agreement with the published data (17) , but the overall concentrations were lower as compared with adults (15). M-ficolin cord blood concentration increased with gestational age, although less as compared with the hepatically synthesized lectin pathway components (5, 18) . We have previously described an increase of M-ficolin over the first year of life in a cohort including controls from this study (19) .
M-ficolin cord blood concentrations were strongly correlated with absolute phagocyte counts and with both mature and immature neutrophils (16) . We have confirmed this recently in an independent cohort of children with cancer, where M-ficolin serum concentration was correlated with phagocyte counts in peripheral blood and in bone marrow (20) . In our current study, we found that granulocyte M-ficolin surface expression was positively correlated with increased CD16 surface expression. CD16 is differentially expressed during granulocyte development and both bands and segmented neutrophilic granulocytes show a high CD16 surface expression (21, 22) . Rorvig et al. (14) previously reported increasing M-ficolin mRNA expression in adult myelocytes/metamyelocytes as compared with myeloblasts/ promyelocytes and band/segmented cells.
Significantly higher M-ficolin cord blood concentrations were found in infants with EOS as compared with controls. Multivariate analysis confirmed that M-ficolin concentrations >1,000 ng/ml were associated with a 10-fold increased risk of EOS. Although exposure to maternal chorioamnionitis may affect both M-ficolin concentrations and phagocyte counts at birth, the results of the multivariate analyses indicate that culture-proven EOS contributes to higher M-ficolin levels independently of chorioamnionitis and phagocyte counts. We observed a similar association between high M-ficolin and This clinical observation is supported in an in vitro bacteremia model assessing M-ficolin release after bacterial challenge. We were able to show a time-and dose-dependent release of M-ficolin in whole blood after exposure to E. coli and to S. typhimurium. This was also observed when isolated cells were studied: a high M-ficolin release was seen from isolated granulocytes, while PBMCs released less M-ficolin. The stimulation experiment was performed using adult blood cells as the amount of blood needed was considered too large for neonates. Future studies should quantitatively compare preterm, term, and adult phagocytes in their ability to express and secrete M-ficolin during sepsis.
Notably, M-ficolin concentrations were correlated with left shift, i.e., I/T ratio, which is an established laboratory marker of neonatal infection (23) . In contrast to commonly used acute-phase markers, M-ficolin may potentially be of interest as a direct marker of neutrophil activity. Prospective studies with sequential determinations of M-ficolin in patients with neonatal sepsis are needed to assess the sensitivity and specificity of elevated M-ficolin.
In spite of the close structural and functional similarities between M-ficolin and MBL, little is known about the physiological role of M-ficolin. M-ficolin serves as a patternrecognition molecule and binds to surface structures containing acetyl groups, such as N-acetyl-d-glucosamine and N-acetylgalactosamine, which are presented by a large variety of pathogens. Recently, M-ficolin has been shown to bind to group B streptococcus, an important pathogen causing EOS (7, 11, 12, 24) . Furthermore, M-ficolin can bind via its fibrinogen-like domain to C-reactive protein, which enhances the binding of C-reactive protein to bacteria and activates the lectin pathway of complement (25, 26) . This pattern-recognition receptor crosstalk is evolutionarily highly conserved, suggesting a crucial function for the initiation of the inflammatory response. Given that neutrophils represent the first and most numerous immune cells to encounter invading pathogens (27) , M-ficolin release by neutrophils may permit the rapid increase of local M-ficolin concentrations in an infectious focus, thereby enhancing opsonization and bactericidal capacity.
We believe that this study has several strengths. M-ficolin concentrations were determined using time-resolved immunofluorometric assay (TRIFMA), an assay that is far superior to enzyme-linked immunosorbent assay in terms of sensitivity, Articles Schlapbach et al.
dynamic range, and reproducibility (15) . In our study, the definition of sepsis required the presence of both positive blood cultures and clinical signs of infection, avoiding false diagnosis due to potential contaminations. Furthermore, patients were carefully matched with controls for gestational age, sex, and chorioamnionitis, which strongly influence the risk of sepsis. However, possible limitations need to be addressed. Only infants in whom cord blood was available were included. A selection bias, however, seems unlikely, as cord blood was routinely taken for determining Toxoplasma gondii serostatus in infants with unknown or negative maternal serologies. Second, similar to many studies assessing acute-phase markers in neonates (23), the small sample size reduces power and as a consequence the results need to be considered preliminary, warranting confirmation by larger prospective studies.
In conclusion, we report that M-ficolin cord blood concentrations were increased in infants with EOS. M-ficolin was secreted upon exposure of phagocytes to bacteria and M-ficolin serum concentration was related to circulating phagocytes. These preliminary results suggest that M-ficolin is involved in the early innate immune response against bacterial infections and may provide a basis for an improved understanding of the biological role of this pattern-recognition molecule. Future studies should investigate whether M-ficolin may be used as a direct marker of neutrophil activation in the course of infection.
MetHods
Patients
Infants born between November 2002 and November 2007 at the Department of Obstetrics, University of Bern, Switzerland, were eligible for this study if cord blood serum had been retrieved and stored. Sepsis cases were defined as infants fulfilling all of the following criteria: (i) clinical signs of sepsis (temperature instability, irritability, apatheia, feeding difficulties, prolonged capillary refill, apnea, tachycardia, tachypnea); (ii) abnormal infectious parameters (C-reactive protein >20 mg/l, leukocytes <5 ×10 9 /l, immature/total neutrophil ratio >0.2); (iii) recovery of pathogens in blood culture within the first 30 days of life; and (iv) treatment for at least 7 days with intravenous antibiotics (28) . Blood cultures yielding either coagulase-negative staphylococci or S. aureus were considered to be contaminants if the infant did not fulfill all the aforementioned criteria, or if the attending physician had considered the bacterium to be a contaminant. The study was approved by the institutional review board (Kantonale Ethikkommission Bern, Bern, Switzerland). The study of cord blood sera was approved by the same review board based on the institutional policy on use of stored biological material. Informed consent was obtained for flow cytometric and stimulation assays.
Controls and Matching Criteria
For each patient, two controls who did not suffer from infections during the neonatal period were matched for the following criteria: (i) gestational age (±1 week); (ii) sex; (iii) chorioamnionitis, defined as maternal fever, elevated maternal C-reactive protein, fetal tachycardia, prolonged rupture of membranes, and/or placental histology indicative of chorioamnionitis (29) . Infants were not eligible as controls if they had developed proven or probable neonatal infection or if they had received antibiotic treatment for suspected neonatal infection for >72 h.
Differential leukocyte counts were routinely obtained at admission to the neonatal intensive care unit. The first differential leukocyte count after birth, if taken within a maximum of 12 h after birth, was included in the analysis.
M-ficolin Measurements
Cord blood is routinely collected and stored at our institution to determine T. gondii serology in the infants of mothers with unknown or negative serostatus. After centrifugation, cord blood sera were frozen in sterile tubes at −80 °C. 
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M-ficolin and early-onset sepsis
The concentrations of M-ficolin were measured by TRIFMA as previously described (15) . TRIFMA is a sandwich assay taking advantage of the long-lasting fluorescence of the europium ion, which can be measured with great sensitivity by photon counting without interference from the rapidly fading background fluorescence. The assay uses a monoclonal antibody specific for M-ficolin (7G1) for coating and biotinylated 7G1 (followed by europium-labeled streptavidin) for development.
Flow Cytometric Analysis
Whole cord blood (stabilized with citrate; 100 μl) was added to 5-ml fluorescence-activated cell-sorting tubes (55.476; Sarsted, Nümbrecht, Germany) and Fc receptors were blocked by adding 10 μg heat-aggregated normal mouse IgG. This was prepared by incubating normal mouse IgG at 63 °C for 30 min. Specific antibodies were then added and incubated for 30 min at room temperature in the dark. Red blood cells were lysed by adding 2 ml BD FACS lysis solution (349202; BD Biosciences, San Jose, CA) and incubating for 10 min at room temperature in the dark. After centrifugation and wash in Tris-buffered saline/azide/0.5% human serum albumin (10 mmol/l Tris, 140 mmol/l NaCl, 15 mmol/l NaN 3 , pH 7.4 (Tris-buffered saline/ azide) with 0.5% (w/v) human serum albumin), the cells were fixed in 0.9% formaldehyde (v/v) in phosphate-buffered saline (137 mmol/l NaCl, 8.1 mmol/l Na 2 HPO 4 , 2.7 mmol/l KCl, 1.5 mmol/l KH 2 PO 4 , pH 7.4). The cells were analyzed on a flow cytometer (Cytomics FC500; Beckman Coulter, Brea, CA) and the data were analyzed using FlowJo (Treestar, Ashland, OR), and compensated via the fluorescenceminus-one method. For each sample, 30,000 cells were analyzed.
Antibodies against the following antigens were used (clones in parentheses): CD16-PE (B73.1), CD45-PerCP (2b1; BD Bioscience); CD66abce-FITC (Kat4c; Dako, Glostrup, Denmark). The following isotype controls were used (clones in parentheses): IgG1-PE (DAK-GO1; Dako); IgG1-PerCP (MOPC-31C; BD Bioscience). Monoclonal anti-M-ficolin antibody (7G1) and its corresponding isotype control (mouse IgG1 kappa , M-7894; Sigma-Aldrich, St Louis, MO) purified on protein G from ascites) were fluorescein-labeled with fluorescein-5-EX N-hydroxysuccinimide ester (F9551; SigmaAldrich) following the manufacturers' protocol.
Granulocyte Isolation
Granulocytes were isolated from freshly drawn blood. Blood was collected by venipuncture from healthy adults into citrate-venoject tubes. The blood was diluted with an equal amount of 3% dextran-3% (w/v) dextran 500 (31392-50G; Sigma-Aldrich) in 0.9% NaCl-and mixed. The mixture was incubated for 45 min at room temperature, and the supernatant was collected and the cells sedimented (10 min at 200g, 4 °C). The pellet was resuspended in cold H 2 O for 30 s to lyse the red blood cells. Tonicity was restored by adding 1.8% NaCl. The cells were sedimented (10 min at 200g, 4 °C), resuspended in cold phosphate-buffered saline and layered on top of Ficoll-Paque PLUS (GE Healthcare, Waukasha, WI), followed by centrifugation for 30 min at 500g, 4 °C. The pelleted granulocytes were washed once and resuspended in binding buffer-10 mmol/l Tris, 140 mmol/l NaCl, pH 7.4 (Tris-buffered saline) with 0.5% (w/v) human serum albumin and 2 mmol/l CaCl 2 .
PBMC Isolation
PBMCs were isolated from freshly drawn blood collected by venipuncture from healthy adults into citrate-venoject tubes. The blood was diluted with an equal amount of 0.9% NaCl, layered on top of FicollPaque PLUS, and centrifuged for 25 min at 900g, 20 °C. The PBMCs were harvested, washed once, and resuspended in binding buffer.
Stimulation With E. coli E. coli (Y1090) was grown on blood agar plates at 37 °C. A single colony was transferred to 10 ml of Luria-Bertani medium and incubated for 24 h at 37 °C. This bacteria stock was kept at 4 °C. Before the bacteria were to be used in the stimulation experiment, 250 µl of the stock was resuspended in 10 ml Luria-Bertani medium and incubated for 24 h at 37 °C. This was repeated once. To estimate the concentration of the bacteria, colony-forming units on blood agar plates were counted.
Granulocytes (4 × 10 6 ) in 1 ml binding buffer, PBMCs (2 × 10 6 ) in 1 ml binding buffer, or 1 ml whole blood (stabilized with citrate; all isolated from adult blood donors) were incubated with different concentrations of E. coli (1.1 ml total volume). The tubes were incubated for 0.5 or 3 h at 37 °C, with gentle mixing every 15 min. The supernatant was collected by centrifugation (10 min at 400g). To ensure the removal of residual bacteria, the supernatant was further centrifuged (15 min at 6,000g). The supernatants were analyzed by TRIFMA.
Statistical Analysis
Association of M-ficolin concentration with sepsis, with EOS vs. lateonset sepsis (EOS, within 72 h of life; late-onset sepsis, >72 h of life), and with gram-positive vs. gram-negative sepsis was investigated using uni-and multivariate logistic regression. First, association with numeric M-ficolin concentration was assessed. Second, by means of receiver-operating-characteristic curve analysis, the optimal cutoff was defined. Gestational age, chorioamnionitis, mode of delivery, mechanical ventilation, and absolute phagocyte count were included as covariates in multivariate analyses. Sensitivity analyses using mixed logistic regression with random-effects per patient-control triplets confirmed the results (R 2.10.1; R Foundation for Statistical Figure 5 . release of M-ficolin after experimental bacteremia. Escherichia coli was added in increasing inocula to (a) 1 ml citrated whole blood, (b) 2 × 10 6 isolated peripheral blood mononuclear cells (PBMcs), or (c) 4 × 10 6 granulocytes. controls with no E. coli exposure are represented on the left (three bars at the left end of the panels). M-ficolin was measured in the supernatant before adding E. coli, and after 30 min and 3 h of incubation with E. coli. (d) control experiment showing no release of MBl (gray bars), H-ficolin (white bars), or l-ficolin (black bars) after experimental bacteremia. E. coli (10 8 ) was added to citrated whole blood. controls with no E. coli exposure are represented on the left for each protein (start and 3 h). MBl, H-ficolin, and l-ficolin were measured in the supernatant after 30 min and 3 h of incubation with E. coli. MBl, mannan-binding lectin.
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Computing, Vienna, Austria; data not shown). Spearman's rank correlation and multivariate linear regression were used to assess the association of logarithmized M-ficolin concentrations with differential leukocyte counts. Two-sided tests were used throughout, and P values <0.05 were considered significant. SPSS 18.0 software was used (SPSS, Chicago, IL).
